The World Health Summit brings together leading researchers, physicians, government officials and representatives from industry, non-governmental organizations (NGOs) and health care systems worldwide.
Among the confirmed speakers are:
(in alphabetical order)
Tedros Adhanom Ghebreyesus Tedros Adhanom Ghebreyesus, elected for a five-year term in May 2017, is the first WHO Director-General to have been elected from multiple candidates by the World Health Assembly, and is the first person from the WHO African Region to serve as WHO's chief technical and administrative officer. Prior to this election, he served as Ethiopia’s Minister of Foreign Affairs from 2012–2016. He served as Ethiopia’s Minister of Health from 2005–2012. In 2009, he was elected as Chair of the Global Fund to Fight AIDS, Tuberculosis, and Malaria Board.
Mazda Adli is a renowned expert for treatment of depression and stress-associated diseases. His focus lies on the topic “mental health for the urban population” and on the treatment and prevention of stress-associated mental diseases in our modern living environment. In 2009, he co-founded the World Health Summit with Detlev Ganten.
Klaus M. Beier is in charge of the undergraduate training of medical students in sexual medicine as well as postgraduate training for physicians and psychologists in this field. He is in charge of the outpatient clinic of the institute which offers assessment and treatment of the full range of sexual disorders and gender dysphorias. His current research focuses on the prevention of child sexual abuse.
Seth Berkley is Gavi’s CEO and d medical doctor specializing in infectious disease epidemiology. He founded the International AIDS Vaccine Initiative (IAVI) in 1996, where he served as President and CEO. Prior to that, he worked for the Health Sciences Division at The Rockefeller Foundation, held posts at the Center for Infectious Diseases, the US Centers for Disease Control; the Massachusetts Department of Public Health; and the Carter Center, where he was assigned as an epidemiologist to the Ministry of Health in Uganda.
An accomplished Corneal Surgeon and Ophthalmologist, Hélène Boisjoly is the first woman to hold the position of Dean of Faculty of Medicine at the University of Montreal and within the greater province of Quebec. She was the International President of the World Health Summit 2017.
Dr. Albert Bourla is the Chief Operating Officer (COO) of Pfizer, one of the world's premier innovative biopharmaceutical companies. As COO, Bourla oversees the company's commercial, strategy, manufacturing and global product development functions. He has almost 25 years of experience with Pfizer and has held a number of senior global positions across a range of markets and disciplines. Bourla is currently a board member of the Pfizer Foundation and the Biotechnology Innovation Organization (Bio), where he serves on the Executive Committee.
Prior to joining IFPMA, Thomas B. Cueni was Secretary General of Interpharma, the association of pharmaceutical research companies in Switzerland. For many years, he has been involved in the work of the European Federation of Pharmaceutical Industries and Associations, EFPIA, where he most recently served as Vice-Chair of the European Markets Committee and association representative on the Board. Prior to his appointment with Interpharma, he had a career as a journalist.
Working for the NCD Alliance since its founding in 2009, Katie Dain holds experience in organizational and strategic development, global advocacy and policy-making, program design as well as capacity-building in low- and middle-income countries. Before joining the NCD Alliance, she worked at the International Diabetes Federation in Brussels, leading their global advocacy program and establishing the first Women and Diabetes program.
Steve Davis, president and CEO of PATH, combines extensive experience as a technology business leader, global health advocate, and social innovator to accelerate great ideas and bring lifesaving solutions to scale. Over his career he has worked extensively on refugee programs and policies and Chinese politics and law. Davis is currently a lecturer on social innovation at the Stanford Graduate School of Business. He is also a member of the Council on Foreign Relations and sits on several advisory groups, including as a trustee of the World Economic Forum’s Global Health Challenge.
Before joining Wellcome in October 2013, Jeremy Farrar was Director of the Oxford University Clinical Research Unit in Vietnam for 18 years. His research interests were infectious diseases, tropical health and emerging infections. He has published over 500 peer-reviewed scientific papers and served as Chair on several advisory boards for governments and global organisations, including the World Health Organization. He is also a Fellow of both the Academy of Medical Sciences and the Royal Society.
Diane Gashumba is the Rwandan Minister of Health of the Republic of Rwanda since October 4, 2016. From March 29, 2016, she served as the Minister of Gender and Family Promotion. She is a pediatrician by profession bringing in much experience in global maternal, newborn and child health with focus to gender issues. She was Director of two district hospitals and President of the National Women Council, thus bringing in strong experience in empowering women.
Richard J. Hatchett, MD, is Chief Executive Officer of the Coalition for Epidemic Preparedness Innovations (CEPI), a partnership of public, private, philanthropic and civil organizations that finances and co-ordinates the development of vaccines against emerging infectious diseases with pandemic or epidemic potential. Prior to joining CEPI, Dr. Hatchett served as the U.S. Biomedical Advanced Research and Development Authority’s (BARDA) Chief Medical Officer and Deputy Director. Following this he became acting Director of BARDA. Previously, Dr. Hatchett served on the Homeland Security Council under President George W. Bush and was a member of the National Security Staff under President Barack Obama.
Martin Hirsch holds his current position since November 2013. He used to be Head of the Emmaüs France, High Commissioner for Active Solidarity against Poverty, and the High Commissioner for Youth in the government of François Fillon. He holds a master's degree in Neurobiology and is an alumnus of the École Normale Supérieure and of the École Nationale d'Administration.
Adnan Hyder is Professor and Associate Chair in the Department of International Health. He is the Director of the Health Systems program, Director of the International Injury Research Unit, and Associate Director of Global Programs at the Johns Hopkins Berman Institute of Bioethics. He serves as Co-Director of the NIH-Fogarty International Research Ethics Training Program at the Bloomberg School of Public Health.
Ambassador Ischinger is Chairman of the Munich Security Conference (MSC) and Senior Professor for Security Policy and Diplomatic Practice at the Hertie School of Governance in Berlin. He has served as German Deputy Foreign Minister (State Secretary) and as Germany's Ambassador in Washington, D.C. and London. In 2015, he chaired an OSCE-mandated ‘Panel of Eminent Persons on European Security as a Common Project’. From 2008 to 2014, he was also Global Head of Government Relations at Allianz SE, Munich. He is a member of a number of non-profit and corporate boards.
Zsuzsanna Jakab has engaged first hand with many partners and WHO member states, contributing to the formulation of a joint health agenda for the WHO European Region and working for the WHO Europe in a range of senior management roles. Between 2002 and 2005, she was State Secretary at the Hungarian Ministry of Health, Social and Family Affairs. Prior to that, she served as the founding Director of the European Union's European Centre for Disease Prevention and Control in Stockholm, Sweden.
As a leading contributor to academic and political debates on governance for health at a national and global level, Ilona Kickbusch conducts global health diplomacy seminars in many regions and advises the World Health Organization (WHO). In Switzerland, she serves on the executive board of the Careum Foundation and as an advisor for Health 2020.
Susanna Krüger is CEO and board member at Save the Children Germany e.V since March 2016. Before, she founded and led GoodRoots, an advisory firm working with social investors on their impact measurement and organizational change. Her work experience includes over 14 years in development cooperation as well as humanitarian aid and its evaluation (Middle East, Asia and Africa), public administration reform, facilitation of organizational change in the non-profit sector, strategic philanthropy and impact investing efforts with large European foundations.
Justin McCarthy is the Senior Vice President of Global Policy and International Public Affairs at Pfizer Inc. In this role, he is responsible for defining Pfizer’s public policy positions and advancing government and public affairs strategies internationally. Prior to this role, McCarthy was the Chief Counsel for Pfizer’s Worldwide Research and Development division and responsible for Pfizer's global Intellectual Property activities. He serves on the Boards of the Business Council for International Understanding, the Global Intellectual Property Center (GIPC), and the United States Council for International Business.
Dr. Angela Merkel is the first female chancellor of Germany and one of the architects of the European Union. Dr. Merkel was born in Hamburg, Germany and studied physics at the University of Leipzig, earning a doctorate, and later worked as a chemist. After the fall of the Berlin Wall in 1989, Merkel joined the Christian Democratic Union (CDU) political party and was appointed to Helmut Kohl's cabinet as minister for women and youth. In 2000, Merkel was chosen party leader and won the 2005 election by just three seats. After the CDU agreed to a coalition deal with the Social Democrats (SPD) she was declared Germany's first female chancellor. She was elected to a second term in 2009, a third term in 2013 and a fourth term in 2017.
He leads the foundation’s efforts in research and development of vaccines, drugs, and diagnostics to address major global health challenges in the developing world. He oversees the foundation’s strategies in HIV, tuberculosis, malaria, pneumonia, diarrheal disease, enteric and diarrheal diseases, and neglected infectious diseases. Prior to joining the foundation in 2011, he was global head of development with Novartis, and previously was involved in clinical research at Pfizer and Parke-Davis.